• Consumer Stories
  • People-first Pharmacy Care

Small pharmacy makes big COVID-19 vaccine impact

Jul 30th, 2021

Vaccine Impact News: From Troy, New York

The Genoa Healthcare pharmacy located within the Unity House of Troy may be on the small side, but it has made a big impact in its Troy, New York, community by administering COVID-19 vaccines.


The pharmacy was one of the first Genoa Healthcare sites in New York State to receive the vaccine. The pharmacy team wasted no time letting consumers and staff members know that the vaccine was available to them, and communicating about vaccine ability with the broader community. A few weeks ago, the pharmacy — which serves about 160 people per month — hit a major milestone of 1,000 vaccine shots administered.


“The first few weeks we were fielding hundreds of calls and inquiries a day,” said Kristen Bohne, site manager for the Troy, New York, Genoa pharmacy. “Once vaccine demand slowed, we continued working hard to ensure people knew there were available vaccines at our site. Our clinic also provides a daily free meal to members of the community, so every day we would connect with those people to sign them up for the vaccine.”


The Troy pharmacy is located in an underserved area, and Bohne said that being able to administer vaccines to people who don’t have permanent housing, have high anxiety levels or do not feel comfortable entering a hospital or a large clinic has helped build a sense of community.


People with serious mental illness are at an increased risk of contracting COVID-19 and are also more likely to be hospitalized and experience serious complications, including death. This group faces additional barriers to vaccination and limited access to preventive care.


Consumers feel comfortable at Unity House and the Genoa pharmacy, which has helped ensure people return for their second doses, Bohne added. “People were extremely appreciative of the opportunity to be vaccinated,” she said.

Site manager Kristen Bohne and her team in Troy, New York, recently reached a milestone of administering 1,000 COVID-19 vaccinations.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
4 things to know about Spravato® (Intranasal esketamine)

On January 21, 2025, the FDA announced the approval of Spravato® nasal spray as a monotherapy treatment for treatment-resistant depression (TRD), making this medication the first and only monotherapy option...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa’s 2024 Art Celebration: Celebrating the healing power of creativity

“I’ve always expressed myself through my art and learned to use my creativity to inspire others”, says Genoa Healthcare 2024 Art Celebration participant Shanelle G. Genoa’s annual Art Celebration invites...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Esketamine: Latest research offers new hope for adolescents with treatment-resistant depression

Adolescents with treatment-resistant depression (TRD) often struggle with a lack of effective treatment options. While ketamine has been shown to help improve outcomes for adults living with major depressive disorder...

  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...